Longitude Capital

Longitude Capital

Total funding
$48.3M in 2 rounds from 5 investors
By Longitude Capital
$35.5M Series B in Jul, 2017
Total funding
$73M in 1 rounds from 9 investors
By Longitude Capital
$73M Series A in Mar, 2020
Total funding
$135M in 2 rounds from 20 investors
By Longitude Capital
$70M Series B in Dec, 2017
Total funding
$40M in 2 rounds from 3 investors
By Longitude Capital
$25M Series B in Jun, 2012
Total funding
$146.2M in 6 rounds from 11 investors
By Longitude Capital
$20.1M Venture Capital in Apr, 2018
Total funding
$17M in 2 rounds from 4 investors
By Longitude Capital
$17M Debt financing in Jun, 2015
Total funding
$88M in 2 rounds from 8 investors
By Longitude Capital
$53M Series C in Apr, 2021
Total funding
$134M in 3 rounds from 15 investors
By Longitude Capital
$85M Series C in Jun, 2020
Total funding
$60M in 3 rounds from 5 investors
By Longitude Capital
$34M Venture Capital in Oct, 2017
Total funding
$50M in 1 rounds from 3 investors
By Longitude Capital
$50M Series B in May, 2020
Total funding
$206.6M in 6 rounds from 20 investors
By Longitude Capital
$71M Series E in Jul, 2020
Total funding
$62M in 1 rounds from 2 investors
By Longitude Capital
$62M Series A in Jan, 2021
Total funding
$85M in 1 rounds from 4 investors
By Longitude Capital
$85M Series A in Dec, 2019
Total funding
$58M in 3 rounds from 5 investors
By Longitude Capital
$40M Series A in Nov, 2018
Total funding
$67M in 1 rounds from 9 investors
By Longitude Capital
$67M Series A in Apr, 2019
Total funding
$109.2M in 4 rounds from 14 investors
By Longitude Capital
$68M Series C in Apr, 2016
Total funding
$32.9M in 1 rounds from 5 investors
By Longitude Capital
£25M Series C in Aug, 2018
Exit Bayer, Aug 11, 2020
Total funding
$60M in 1 rounds from 5 investors
By Longitude Capital
$60M Post-IPO equity in Aug, 2017
Total funding
$13M in 2 rounds from 3 investors
By Longitude Capital
$8.5M Series B in May, 2018
Total funding
$40M in 1 rounds from 6 investors
By Longitude Capital
$40M Venture Capital in Jun, 2020
Total funding
$282.5M in 3 rounds from 14 investors
By Longitude Capital
$142M Series C in Apr, 2019
Total funding
$87.5M in 12 rounds from 27 investors
By Longitude Capital
$15M Series D in Dec, 2013
Total funding
$274.9M in 8 rounds from 16 investors
By Longitude Capital
$120M Venture Capital in May, 2020
Total funding
$22M in 2 rounds from 2 investors
By Longitude Capital
$4.8M Venture capital in Mar, 2010
Total funding
$75M in 2 rounds from 8 investors
By Longitude Capital
$64M Series C in Jun, 2020
Total funding
$277M in 4 rounds from 12 investors
By Longitude Capital
$110M Series D in Mar, 2020
Total funding
$100M in 1 rounds from 3 investors
By Longitude Capital
$100M Series A in Apr, 2019
Total funding
$377.3M in 3 rounds from 6 investors
By Longitude Capital
$55M Series C in Jul, 2016
Total funding
$48M in 2 rounds from 4 investors
By Longitude Capital
$10M Venture capital in May, 2014
Total funding
$65M in 3 rounds from 4 investors
By Longitude Capital
$45M Series A in Mar, 2016
Exit Nabriva Therapeutics, Jul 24, 2018

Want to see the complete list?
Go Pro!